Heparin and its mimetics show promise in selectively inhibiting heparanase expression while also targeting essential mediators such as fibroblast growth factors (FGFs) and the vascular endothelial growth factor (VEGF) involved in tumor angiogenesis [173,178,179,180]. The gene discussed is VEGFA; the disease is neoplasm.